IL6 and diabetes mellitus: On the other hand, elevated circulating levels of sub clinical inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6) are reported to be significant risk indicators not only for the development of cardiovascular disease, but also for the development or progression of diabetes (9).